GADx’s BotrytisAlert now detects fungal crop pathogen across several critical points in wine production

Global Access Diagnostics (GADx), a social enterprise and leading developer of lateral flow and rapid diagnostic technologies, today announced it has expanded the applications of its low-cost, rapid diagnostic test, BotrytisAlert.

FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

FDA staff raised familiar safety concerns about sotagliflozin as a treatment for type 1 diabetes (T1D) as the agency again considers an approval, though now

October 31, 2024

AbbVie signs agreement to acquire Aliada for $1.4bn

The acquisition will include Aliada’s ALIA-1758, which is in development for Alzheimer’s disease. Credit: Art_Photo/Shutterstock. AbbVie has entered a definitive agreement to acquire all outstanding

October 29, 2024

Pharmalittle: We’re reading about Express Scripts overcharging postal workers, Gilead’s AIDS drug price, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so familiar routine of online

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.